Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells

Estefan ía Paula Juliá, Analía Amante, María Betina Pampena, José Mordoh, Estrella Mariel Levy
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research